Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Mark ter Laan"'
Autor:
Lenneke A. M. Cornelissen, Kim C. M. Santegoets, Esther D. Kers-Rebel, Sandra A. J. F. H. Bossmann, Mark Ter Laan, Daniel Granado, Gosse J. Adema
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 953 (2024)
The tumor microenvironment of glioblastoma IDH-wildtype is highly immune suppressive and is characterized by a strong component of myeloid-derived suppressor cells (MDSCs). To interfere with the immune suppressive functions of MDSCs, a comprehensive
Externí odkaz:
https://doaj.org/article/97a25e7e2fbb4e2a8bccf18503ec2409
Autor:
K. Gousias, A. Hoyer, L.A. Mazurczyk, J. Bartek, Jr., M. Bruneau, E. Celtikci, N. Foroglou, C. Freyschlag, R. Grossman, C. Jungk, P. Metellus, D. Netuka, R. Rola, P. Schucht, C. Senft, F. Signorelli, A.J.P.E. Vincent, M. Simon, Rachit Agrawal, Luigi Albano, George A. Alexiou, Amanj Ali, Rafid Al-Mahfoudh, Michael Amoo, Christos Anagnostopoulos, Sven Bamps, Soham Bandyopadhyay, Damiano G. Barone, Fabio Barone, Sami Barrit, Felix Behling, Alin Blaga, Alexandros Boukas, Paul Brennan, Vicki M. Butenschoen, Mauro Campello, Areda Cara, Salvatore Chibbaro, Robert Chrenko, Pere J. Cifre Serra, Hans Clusmann, Alba Corell, Jan F. Cornelius, Marcello D'Andrea, Andreas K. Demetriades, Steven De Vleeschouwer, Richard Drexler, Johnny Duerinck, Ruben V. Fanarjyan, Alejandro Fernandez-Coello, Kostas Fountas, Thomas M. Freiman, Vadim Gadzhiagaev, Miltiadis Georgiopoulos, Nathalie Gilis, Jagos Golubovic, Eric Goulin Lippi Fernandes, Giovanni Grasso, Francesco Guerrini, Beste Gulsuna, Ciaran S. Hill, Julius Höhne, Markus Holling, Ievgenii Iarmoliuk, Florian Ioan-Alexandru, Tamara Ius, Kestutis Jacikevicius, Asgeir S. Jakola, Paweł Jakubowski, Georgios Kalantzis, Konstantina Karabatsou, Ramez Kirollos, Ralph König, Danil A. Kozyrev, Dietmar Krex, Barbara Ladisich, Ruth Lau, Yauhen Lizunou, Arnaud Lombard, Hu Liang Low, José Luís Alves, Yazid Maghrabi, Marco Mammi, Ala Marji, Luca Massimi, Ioannis Mavridis, Aaron Lawson McLean, Anna C. Lawson McLean, Bernhard Meyer, Malte Mohme, Pedro Moura Branco, Michael Müther, Issam Musleh, Danial Nasiri, Ramon Navarro, Ibrahim Omerhodzic, Marvin Darkwah Oppong, Nikolaos A. Paidakakos, Zoi Pantera, Mohammed A. Patel, Mateusz Pawlowski, Athanasios Petridis, Adrian J. Praeger, Stephen Price, Franz Ricklefs, Luigi Rigante, Florian Ringel, Pierre A. Robe, Karl Rössler, Eduarda Sá-Marta, Jose L. Sanmillan, Alba Scerrati, Matthias Schneider, Henry W.S. Schroeder, Michael Schwake, Mohamed Shoaib, Octavian Mihai Sirbu, Iñigo L. Sistiaga, Tomasz J. Skajster, Albertas Sliauzys, Vitaly Sokotukhin, Jehuda Soleman, Veit M. Stoecklein, Eric Suero Molina, Wojciech Świątnicki, Νikolaos Syrmos, Graziano Taddei, Avin Taher, Martin Tamarit, Mark ter Laan, Theocharis Theocharous, Dieter Thijs, Leonidas Trakolis, Monica Truffelli, Miriam Weiss, Eberhard Uhl, Laura Grazia Valentini, Dimitri Vanhauwaert, Bassel Zebian, Bojana Zivkovic, Matteo Zoli
Publikováno v:
Brain and Spine, Vol 4, Iss , Pp 102822- (2024)
Introduction: Technical advances and the increasing role of interdisciplinary decision-making may warrant formal definitions of expertise in surgical neuro-oncology. Research question: The EANS Neuro-oncology Section felt that a survey detailing the
Externí odkaz:
https://doaj.org/article/7f49478772354355ba44b80617e9e219
Autor:
Céline L.G. Neutel, Ilaria Viozzi, Christiaan G. Overduin, Anne Rijpma, Janneke P.C. Grutters, Gerjon Hannink, Pieter van Eijsden, Pierre A. Robe, Maroeska M. Rovers, Mark ter Laan
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Glioblastoma (GBM) is the most common primary, malignant brain tumour with a 5-year survival of 5%. If possible, a glioblastoma is resected and further treated with chemoradiation therapy (CRT), but resection is not feasible in ab
Externí odkaz:
https://doaj.org/article/0a533cfb59e2416ebe4b2fb2d52c9223
Autor:
Rik van den Elshout, Siem D. A. Herings, Manoj Mannil, Anja M. M. Gijtenbeek, Mark ter Laan, Robert J. Smeenk, Frederick J. A. Meijer, Tom W. J. Scheenen, Dylan J. H. A. Henssen
Publikováno v:
Cancers, Vol 15, Iss 20, p 4990 (2023)
Distinguishing treatment-related abnormalities (TRA) from tumor progression (TP) in glioblastoma patients is a diagnostic imaging challenge due to the identical morphology of conventional MR imaging sequences. Diffusion-weighted imaging (DWI) and its
Externí odkaz:
https://doaj.org/article/5c0be122eb884cf68ef5bc2a9061cdde
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 101749- (2023)
Introduction: In the last decades, the application of stereotactic laser ablation (SLA) for the treatment of intracranial tumours has been growing, even though comparative trials are lacking. Our aim was to investigate the familiarity with SLA of neu
Externí odkaz:
https://doaj.org/article/d52d6e5d02d2488f977a73f349643856
Autor:
Dylan Henssen, Lars Leijten, Frederick J. A. Meijer, Anja van der Kolk, Anne I. J. Arens, Mark ter Laan, Robert J. Smeenk, Anja Gijtenbeek, Elsmarieke M. van de Giessen, Nelleke Tolboom, Daniela E. Oprea-Lager, Marion Smits, James Nagarajah
Publikováno v:
Cancers, Vol 15, Iss 9, p 2631 (2023)
The post-treatment imaging surveillance of gliomas is challenged by distinguishing tumor progression (TP) from treatment-related abnormalities (TRA). Sophisticated imaging techniques, such as perfusion-weighted magnetic resonance imaging (MRI PWI) an
Externí odkaz:
https://doaj.org/article/39d97467645f41149edcebb2eec89a7d
Autor:
Krissie Lenting, Corina N. A. M. van den Heuvel, Anne van Ewijk, Duaa ElMelik, Remco de Boer, Elizabeth Tindall, Ge Wei, Benno Kusters, Maarten te Dorsthorst, Mark ter Laan, Martijn A. Huynen, William P. Leenders
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Many biology-based precision drugs are available that neutralize aberrant molecular pathways in cancer. Molecular heterogeneity and the lack of reliable companion diagnostic biomarkers for many drugs makes targeted treatment of cancer inaccu
Externí odkaz:
https://doaj.org/article/295b2e41b8a84f889a698d9f2d2d97e1
Autor:
Ang Lin, Sven Brandau, Stephan Lang, Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczynska-Moncznik, Oktawia Osiecka, Xiaoying Hu, Ida Marie Rundgren, Kim Santegoets, Utku Horzum, Ana Godinho-Santos, Gennadiy Zelinskyy, Thalia Garcia-Tellez, Sunčica Bjelica, Bartłomiej Taciak, Astrid Olsnes Kittang, Benedikt Höing, Michael Dixon, Verena Müller, Jochen Sven Utikal, Derya Karakoç, Kerim Bora Yilmaz, Emilia Górka, Olympia Evdoxia Anastasiou, Christine Bourgeois, Robert Badura, Monika Kapinska-Mrowiecka, Mirjana Gotic, Mark ter Laan, Esther Kers-Rebel, Magdalena Król, Juan Francisco Santibañez, Michaela Müller-Trutwin, Ulf Dittmer, Ana Espada de Sousa, Güneş Esendağlı, Gosse Adema, Karin Loré, Elisabeth Ersvær, Viktor Umansky, Jeffrey W Pollard, Joanna Cichy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Myeloid-derived suppressor cells (MDSC) are a functional myeloid cell subset that includes myeloid cells with immune suppressive properties. The presence of MDSC has been reported in the peripheral blood of patients with several malignant
Externí odkaz:
https://doaj.org/article/a204127dcd8f4fbba35c1dcd217e919e
Autor:
Evi J. van Kempen, Max Post, Manoj Mannil, Benno Kusters, Mark ter Laan, Frederick J. A. Meijer, Dylan J. H. A. Henssen
Publikováno v:
Cancers, Vol 13, Iss 11, p 2606 (2021)
Treatment planning and prognosis in glioma treatment are based on the classification into low- and high-grade oligodendroglioma or astrocytoma, which is mainly based on molecular characteristics (IDH1/2- and 1p/19q codeletion status). It would be of
Externí odkaz:
https://doaj.org/article/1052bcf3c6de49918a195c6143e84317
Autor:
Maikel Verduin, Sergey Primakov, Inge Compter, Henry C. Woodruff, Sander M. J. van Kuijk, Bram L. T. Ramaekers, Maarten te Dorsthorst, Elles G. M. Revenich, Mark ter Laan, Sjoert A. H. Pegge, Frederick J. A. Meijer, Jan Beckervordersandforth, Ernst Jan Speel, Benno Kusters, Wendy W. J. de Leng, Monique M. Anten, Martijn P. G. Broen, Linda Ackermans, Olaf E. M. G. Schijns, Onno Teernstra, Koos Hovinga, Marc A. Vooijs, Vivianne C. G. Tjan-Heijnen, Danielle B. P. Eekers, Alida A. Postma, Philippe Lambin, Ann Hoeben
Publikováno v:
Cancers, Vol 13, Iss 4, p 722 (2021)
Glioblastoma (GBM) is the most malignant primary brain tumor for which no curative treatment options exist. Non-invasive qualitative (Visually Accessible Rembrandt Images (VASARI)) and quantitative (radiomics) imaging features to predict prognosis an
Externí odkaz:
https://doaj.org/article/f4f34d3d094745acb5e1e629272e2805